AKT1 and schizophrenia: Taking advantage of the Akt1 heterozygous mutant (Akt1+/−) mouse model of schizophrenia and Akt1-deficient cellular models, we focused on investigating the therapeutic potential of lithium in the alleviation of Akt1-related deficits.